About Prolifagen
Prolifagen is a private company based in Doylestown, Pennsylvania, incorporated in 2025 in Delaware. It has reported $3,026,864 raised in one offering on Form D since September 2025. Its chief executive is Michael Behr.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Sep 2, 2025 | Sep 23, 2025 | $3,026,864target not set | 6 | $504K | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Prolifagen's Form D filed Sep 23, 2025.
MS
M. Shaw
Director
AB
Andreas Bader
Executive officer
WH
William Houston
Executive officer
MB
Michael Behr
Chief Executive Officer and director
CB
Claudine Bruck
Executive officer and director